Israel Englander’s Novavax NVAX Stock Holding History

Israel Englander’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212K	Hold	22,500	–	–	﹤0.01%	5289
2026 Q1	$183K	Sell	22,500 -20,000	-47%	-$181K	﹤0.01%	5211
2025 Q4	$286K	Hold	42,500	–	–	﹤0.01%	5286
2025 Q3	$368K	Buy	+42,500	New	+$331K	﹤0.01%	5249
2024 Q4	–	Sell	-150,000	Closed	-$1.89M	–	6296
2024 Q3	$1.89M	Sell	150,000 -51,300	-25%	-$662K	﹤0.01%	3750
2024 Q2	$2.55M	Buy	+201,300	New	+$2.03M	﹤0.01%	3316
2023 Q4	–	Sell	-125,000	Closed	-$905K	–	6390
2023 Q3	$905K	Buy	+125,000	New	+$999K	﹤0.01%	4252
2022 Q3	–	Sell	-39,000	Closed	-$2.01M	–	7365
2022 Q2	$2.01M	Sell	39,000 -1,000	-3%	-$51.8K	﹤0.01%	3708
2022 Q1	$2.95M	Buy	40,000 +34,500	+627%	+$3.08M	﹤0.01%	3514
2021 Q4	$787K	Buy	+5,500	New	+$945K	﹤0.01%	4636
2021 Q3	–	Sell	-1,000	Closed	-$212K	–	7102
2021 Q2	$212K	Buy	+1,000	New	+$183K	﹤0.01%	5980
2016 Q4	–	Sell	-2,500	Closed	-$104K	–	3599
2016 Q3	$104K	Buy	+2,500	New	+$323K	﹤0.01%	3121

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Israel Englander's NVAX Position: Q2 2026 in Review

Israel Englander reduced its Novavax (NVAX) stake by 54% in Q2 2026, selling an estimated $18.7M and leaving 1,768,163 shares worth $16.7M. The position accounts for 0.01% of the portfolio, ranked #1795.

Israel Englander first reported a position in NVAX in Q3 2013 and has held it in 50 quarters since. The position peaked at $68.9M in Q2 2021. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Israel Englander held 1,768,163 shares of Novavax worth $16.7M as of Q2 2026.
Israel Englander sold 2,084,382 Novavax shares in Q2 2026, an estimated $18.7M.
Novavax made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1795 holding.
Israel Englander first reported a position in Novavax in Q3 2013 and has held it in 50 quarters since.
Israel Englander's Novavax position peaked at $68.9M in Q2 2021.
264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.